SQD.H — SQI Diagnostics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for SQI Diagnostics, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.33 | 1.89 | 1.02 | 0.917 | 8.1 |
| Cost of Revenue | |||||
| Gross Profit | 0.458 | 1.28 | 0.791 | 0.767 | 3.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.77 | 9.91 | 9.59 | 11.5 | 26.6 |
| Operating Profit | -7.44 | -8.02 | -8.57 | -10.6 | -18.5 |
| Net Income Before Taxes | -7.44 | -8.02 | -8.57 | -10.6 | -18.5 |
| Net Income After Taxes | -7.44 | -8.02 | -8.57 | -10.6 | -18.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.44 | -8.02 | -8.57 | -10.6 | -18.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.44 | -8.02 | -8.57 | -10.6 | -18.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.057 | -0.045 | -0.032 | -0.035 | -0.043 |